Concepedia
Statistics
Publications
5
Citations
400
H-Index
Active since
1998
Affiliations
Institut Gustave Roussy(Current)
Inserm
University Hospital of Geneva
Finnish Institute of Occupational Health
Nadejda Jourenkova-Mironova is an author at Institut Gustave Roussy specializing in oncology, medicine, and cancer research.
Top concepts
MedicineOncologyPathologyCancer ResearchGeneticsOral CancerRadiation OncologyLung CancerOral BiologyPharmacology
Publications per year
1998–2000
GlutathioneS-transferaseGSTM1, GSTM3, GSTP1 andGSTT1 genotypes and the risk of smoking-related oral and pharyngeal cancers
Nadejda Jourenkova-Mironova, Anu Voho, Christine Bouchardy et al. · International Journal of Cancer · 1999 · 114 citations
Genetics, Human Polymorphism, Pathology +18
High-activity microsomal epoxide hydrolase genotypes and the risk of oral, pharynx, and larynx cancers.
Nadejda Jourenkova-Mironova, Katja Mitrunen, C Bouchardy et al. · PubMed · 2000 · 94 citations
Cancer Metabolism, Oncology, Ephx1 Gene +14
Role of glutathione S-transferase GSTM1, GSTM3, GSTP1 and GSTT1 genotypes in modulating susceptibility to smoking-related lung cancer
Nadejda Jourenkova-Mironova, Harriet Wikman, Christine Bouchardy et al. · Pharmacogenetics · 1998 · 90 citations
Glutathione S-transferase GSTM3 and GSTP1 genotypes and larynx cancer risk.
Nadejda Jourenkova-Mironova, Anu Voho, Christine Bouchardy et al. · PubMed · 1999 · 70 citations
Larynx Cancer Risk, Cancer Risk, Oncogenic Agent +13
Role of arylamine N-acetyltransferase 1 and 2 (NAT1 and NAT2) genotypes in susceptibility to oral/pharyngeal and laryngeal cancers.
Nadejda Jourenkova-Mironova, Harriet Wikman, Christine Bouchardy et al. · PubMed · 1999 · 32 citations
Oncology, Oncogenic Agent, Medicine +8
1–5 of 5